Filing Details

Accession Number:
0001628280-22-022234
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-10 16:36:59
Reporting Period:
2022-08-08
Accepted Time:
2022-08-10 16:36:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551306 Progyny Inc. PGNY Services-Misc Health & Allied Services, Nec (8090) 272220139
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576145 J David Schlanger C/O Progyny, Inc.
1359 Broadway, 2Nd Fl
New York NY 10018
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-08 41,667 $0.91 124,215 No 4 M Direct
Common Stock Disposition 2022-08-08 200 $41.75 124,015 No 4 S Direct
Common Stock Disposition 2022-08-08 4,000 $43.32 120,015 No 4 S Direct
Common Stock Disposition 2022-08-08 22,666 $44.67 97,349 No 4 S Direct
Common Stock Disposition 2022-08-08 14,601 $45.38 82,748 No 4 S Direct
Common Stock Disposition 2022-08-08 200 $46.09 82,548 No 4 S Direct
Common Stock Acquisiton 2022-08-09 41,667 $0.91 124,215 No 4 M Direct
Common Stock Disposition 2022-08-09 25,367 $40.78 98,848 No 4 S Direct
Common Stock Disposition 2022-08-09 4,986 $42.04 93,862 No 4 S Direct
Common Stock Disposition 2022-08-09 5,214 $42.74 88,648 No 4 S Direct
Common Stock Disposition 2022-08-09 5,200 $43.92 83,448 No 4 S Direct
Common Stock Disposition 2022-08-09 900 $44.66 82,548 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2022-08-08 41,667 $0.00 41,667 $0.91
Common Stock Common Stock Disposition 2022-08-09 41,667 $0.00 41,667 $0.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,692,013 2027-08-03 No 4 M Direct
1,650,346 2027-08-03 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.92 to $43.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.99 to $44.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.08 to $46.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.38 to $41.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.41 to $43.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.57 to $44.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date.